MedPath

A single-center, prospective, open-label study investigating the effect of Ninjin'yoeito on frailty in hemodialysis patients.

Not Applicable
Conditions
frailty in hemodialysis patients
Registration Number
JPRN-UMIN000052058
Lead Sponsor
Japanese Red Cross Kumamoto Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who have difficulty obtaining consent due to dementia 2. Patients with terminal cancer, with acute cardiovascular disease, before and after surgery, and with serious trauma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath